DUBLIN, Nov. 16, 2020 /PRNewswire/ -- The "Immunofluorescence Assays - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Immunofluorescence Assays estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027.
Reagents, one of the segments analyzed in the report, is projected to record a 5% CAGR and reach US$1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $481 Million, While China is Forecast to Grow at 4.1% CAGR
The Immunofluorescence Assays market in the U. S. is estimated at US$481 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$390.3 Million by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
Antibodies Segment to Record 3.8% CAGR
In the global Antibodies segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$149 Million in the year 2020 will reach a projected size of US$193.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$252.7 Million by the year 2027.
The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
- Abcam PLC
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- Danaher Corporation
- INOVA Diagnostics, Inc.
- Medipan GmbH
- MilliporeSigma
- PerkinElmer, Inc.
- Sino Biological Inc.
- Thermo Fisher Scientific, Inc.
- Vector Laboratories, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Immunofluorescence Assay Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
- Market Facts & Figures
- Immunofluorescence Assay Market Share (in %) by Company: 2019 & 2025
- Market Analytics
- Immunofluorescence Assays Market Estimates and Projections in US$ Thousand by Product: 2020 to 2027
- Immunofluorescence Assays Market by Product: A Historic Review in US$ Thousand for 2012-2019
- Immunofluorescence Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
- Immunofluorescence Assays Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
- Immunofluorescence Assays Market by Type: A Historic Review in US$ Thousand for 2012-2019
- Immunofluorescence Assays Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- Immunofluorescence Assays Market Estimates and Projections in US$ Thousand by Disease: 2020 to 2027
- Immunofluorescence Assays Market by Disease: A Historic Review in US$ Thousand for 2012-2019
- Immunofluorescence Assays Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- Immunofluorescence Assays Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
- Immunofluorescence Assays Historic Demand Patterns by End-Use in US$ Thousand for 2012-2019
- Immunofluorescence Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION
- Total Companies Profiled: 42
For more information about this report visit https://www.researchandmarkets.com/r/1a5bpf
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
